Načítá se...

Adenoviruses Using the Cancer Marker EphA2 as a Receptor In Vitro and In Vivo by Genetic Ligand Insertion into Different Capsid Scaffolds

Adenoviral gene therapy and oncolysis would critically benefit from targeted cell entry by genetically modified capsids. This requires both the ablation of native adenovirus tropism and the identification of ligands that remain functional in virus context. Here, we establish cell type-specific entry...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Behr, Michael, Kaufmann, Johanna K., Ketzer, Patrick, Engelhardt, Sarah, Mück-Häusl, Martin, Okun, Pamela M., Petersen, Gabriele, Neipel, Frank, Hassel, Jessica C., Ehrhardt, Anja, Enk, Alexander H., Nettelbeck, Dirk M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3997477/
https://ncbi.nlm.nih.gov/pubmed/24760010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0095723
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!